Uhmontpellier
Montpellier, 34295, France
Location status: Recruiting
NCT Number: NCT04990908
Severe infections in pediatric intensive care unit are not uncommon. Historically, the diagnosis of hereditary (primary) immune deficiency required a combination of recurrent clinical signs and biological stigmas. This paradigm is currently being questioned, and grows the hypothesis of a potential underlying genetic susceptibility in any severe infection. To date, the proportion of severe infections explained by an underlying immune deficiency is unknown.
The aim of this prospective study is to assess the incidence of primary immune deficiencies in children with severe infection, regardless of their etiology.
Interested in participating?
Request Info3 month–16 year
All sexes
Observational
Montpellier, 34295, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
number of patients with primary immunodeficiency revealed after a severe infection in pediatric ICU or in neuropediatric unit
Time frame: 1 day
To evaluate the sensitivity of our systematic screening in relation to an approach scrupulously following the indications of other published studies for the screening of primary immunodeficiencies
Time frame: 1 day
The number of immune deficiencies that have no other call point based on the list of warning signs of the Reference Center for Hereditary Immune Deficiencies (CEREDIH)
Contact information is provided by the study sponsor or research team.
University Hospital, Montpellier
Other
Acronym: SPYSI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07609576
Biespecific, Biespecific Treatment
Madrid, Spain
View Trial DetailsNCT06260345
Hospitalized Children, Infections
Créteil, France
View Trial DetailsNCT04923828
Infections, Severe Infection
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05788861
Infections, Medical Care
Créteil, France
View Trial Details